NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr | ₹-251 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-247 Cr |
Mar2023 | ₹-363 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹-186 Cr |
Mar2020 | ₹-251 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-247 Cr | Negative | |
Mar2023 | ₹-363 Cr | Negative | |
Mar2022 | ₹35 Cr | Positive | |
Mar2021 | ₹-186 Cr | Negative | |
Mar2020 | ₹-251 Cr | - |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹18,500.1 Cr | 7.4% | 17.7% | -15.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 7.4% |
17.7% |
-15.5% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses